Compare ACH & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACH | RPID |
|---|---|---|
| Founded | 1882 | 2006 |
| Country | United States | United States |
| Employees | 6500 | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 217.5M | 204.3M |
| IPO Year | N/A | 2021 |
| Metric | ACH | RPID |
|---|---|---|
| Price | $3.20 | $1.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $3.38 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 666.9K | 137.2K |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $33,587,000.00 |
| Revenue This Year | N/A | $19.12 |
| Revenue Next Year | $4.43 | $18.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $1.84 | $1.66 |
| 52 Week High | $4.69 | $4.94 |
| Indicator | ACH | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 56.14 | 32.01 |
| Support Level | $3.18 | $1.66 |
| Resistance Level | $3.42 | $2.46 |
| Average True Range (ATR) | 0.24 | 0.10 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 76.97 | 9.89 |
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.